Axsome Therapeutics Inc.

103.01
-1.45 (-1.39%)
At close: Apr 21, 2025, 3:59 PM
103.01
0.00%
Pre-market: Apr 22, 2025, 04:07 AM EDT

Axsome Therapeutics Revenue Breakdown

Period Ending Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Product Revenue 103.74M 74.1M 70.75M 57.13M 46.02M 28.57M
Product Revenue Growth +40.00% +4.73% +23.84% +24.14% +61.07% n/a
Royalty Revenue 1.03M 903K 783K 667K 683K 272K
Royalty Revenue Growth +13.62% +15.33% +17.39% -2.34% +151.10% n/a

Revenue by Geography

Period Ending Dec 31, 2023 Dec 31, 2022
Non-Us Revenue 65.73M 900K
Non-Us Revenue Growth +7203.89% n/a
United States Revenue 197.22M n/a
United States Revenue Growth n/a n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 113.27M 95.56M 103.55M 98.97M 86.81M 83.19M 78.94M 74.19M 61.5M 40.89M 31.16M 25.7M 18.83M 20.23M 16.34M 11.25M 10.36M 6.33M 7.24M 4.97M 5.22M 3.11M 2.45M 2.82M 2.3M 2.2M 2.44M 2.41M 1.95M 1.83M 1.74M 1.69M 1.82M 1.64M 1.53M 1.36M 946.62K 499.42K 456.41K 516.84K
Selling, General, and Administrative Revenue Growth +18.53% -7.72% +4.63% +14.01% +4.35% +5.39% +6.39% +20.64% +50.39% +31.23% +21.23% +36.53% -6.92% +23.75% +45.30% +8.58% +63.62% -12.50% +45.59% -4.84% +67.85% +27.26% -13.25% +22.59% +4.38% -9.69% +1.18% +23.61% +6.79% +4.76% +3.35% -7.26% +10.97% +7.18% +12.72% +43.31% +89.54% +9.42% -11.69% n/a
Research and Development Revenue 55.01M 45.39M 49.85M 36.59M 30.8M 28.77M 20.58M 17.79M 14.69M 14.88M 15.79M 12.59M 13.78M 13.18M 14.5M 16.6M 17.38M 14.8M 10.54M 27.52M 19.21M 15.84M 11M 7.6M 7.15M 6.04M 5.55M 4.75M 4.49M 4.47M 5.01M 5.99M 5.81M 5.57M 5.3M 4.53M 2.21M 1.52M 1.63M 1.42M
Research and Development Revenue Growth +21.19% -8.96% +36.26% +18.78% +7.08% +39.77% +15.67% +21.10% -1.24% -5.80% +25.48% -8.68% +4.56% -9.12% -12.61% -4.54% +17.50% +40.34% -61.69% +43.30% +21.28% +43.92% +44.72% +6.32% +18.38% +8.83% +16.79% +5.75% +0.51% -10.71% -16.34% +3.07% +4.27% +5.11% +17.05% +105.00% +44.84% -6.39% +14.98% n/a